Corpus callosum index correlates with brain volumetry and disability in multiple sclerosis patients
- PMID: 32683399
- PMCID: PMC8015480
- DOI: 10.17712/nsj.2020.3.20190093
Corpus callosum index correlates with brain volumetry and disability in multiple sclerosis patients
Abstract
Objective: To analyze the correlation between corpus callosum index (CCI), brain volumetry, and disability in multiple sclerosis (MS) patients. The brain volumetry consists of the corpus callosum, cortical gray matter, subcortical gray matter, and white matter volumes.
Methods: This was a retrospective cross-sectional study from October 2018 to February 2019 of 30 patients with MS aged 20 to 61 years old. Brain volumetry was performed using FreeSurfer software. The CCI were measured manually using conventional best mid-sagittal T1W brain MRI. The anterior, posterior, and medium segments were measured and divided to its greatest anteroposterior diameter. Higher CCI values indicated greater corpus callosum volumes. Clinical evaluation was comprised of MS subtype, age of onset, relapse frequency and Expanded Disability Status Scale (EDSS).
Results: Thirty MS patients with median of age 22 years were included. Relapsing-remitting (RRMS) subtype were 73.3%. Very significant correlations were shown between the CCI and corpus callosum volume (CCV) (r=0.79; p<0.0001) and cerebral white matter volume (r=0.81; p<0.0001). Significant correlations were shown between the CCI and cortical gray matter volume (r=0.64; p<0.0001) and subcortical gray matter volume (r=0.69; p<0.0001). The CCI was positively correlated with age of onset and inversely with EDSS. The CCV and CCI were smaller in secondary progressive MS (SPMS).
Conclusion: The CCI is easy and fast to obtain in conventional MRI and significantly correlated with brain volumetry, age of onset and disability in MS patients.
Figures


Similar articles
-
Correlation between the corpus callosum index and brain atrophy, lesion load, and cognitive dysfunction in multiple sclerosis.Mult Scler Relat Disord. 2018 Feb;20:154-158. doi: 10.1016/j.msard.2018.01.015. Epub 2018 Jan 31. Mult Scler Relat Disord. 2018. PMID: 29414290
-
MRI-Defined Corpus Callosal Atrophy in Multiple Sclerosis: A Comparison of Volumetric Measurements, Corpus Callosum Area and Index.J Neuroimaging. 2015 Nov-Dec;25(6):996-1001. doi: 10.1111/jon.12237. Epub 2015 Mar 19. J Neuroimaging. 2015. PMID: 25786805
-
Corpus callosum atrophy correlates with gray matter atrophy in patients with multiple sclerosis.J Neuroimaging. 2015 Jan-Feb;25(1):62-7. doi: 10.1111/jon.12124. Epub 2014 May 9. J Neuroimaging. 2015. PMID: 24816394 Free PMC article.
-
Predictors of multiple sclerosis progression: A systematic review of conventional magnetic resonance imaging studies.PLoS One. 2024 Apr 16;19(4):e0300415. doi: 10.1371/journal.pone.0300415. eCollection 2024. PLoS One. 2024. PMID: 38626023 Free PMC article.
-
Neuroimaging markers and disability scales in multiple sclerosis: A systematic review and meta-analysis.PLoS One. 2024 Dec 5;19(12):e0312421. doi: 10.1371/journal.pone.0312421. eCollection 2024. PLoS One. 2024. PMID: 39637162 Free PMC article.
Cited by
-
Automatic deep learning multicontrast corpus callosum segmentation in multiple sclerosis.J Neuroimaging. 2022 May;32(3):459-470. doi: 10.1111/jon.12972. Epub 2022 Jan 26. J Neuroimaging. 2022. PMID: 35083815 Free PMC article.
-
Segmentation with artificial intelligence and automated calculation of the corpus callosum index in multiple sclerosis.Saudi Med J. 2025 Jun;46(6):638-648. doi: 10.15537/smj.2025.46.6.20240957. Saudi Med J. 2025. PMID: 40516948 Free PMC article.
References
-
- Brownlee WJ, Hardy TA, Fazekas F, Miller DH. Diagnosis of multiple sclerosis: progress and challenges. Lancet. 2017;389:1336–1346. - PubMed
-
- Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015;15:545–558. - PubMed
-
- Howard J, Trevick S, Younger DS. Epidemiology of Multiple Sclerosis. Neurol Clin. 2016;34:919–939. - PubMed
-
- Garg N, Reddel SW, Miller DH, Chataway J, Riminton DS, Barnett Y, et al. The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases. J Neurol Neurosurg Psychiatry. 2015;86:1374–1382. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical